![]() |
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Antimicrobial resistance is considered a major health threat for patients and healthcare providers. It challenges the control of infectious diseases, jeopardizes any medical progress and imposes huge treatment costs. This study aimed to design an effective antibiotic policy for treatment of different types of infections at Gastrointestinal Surgical Center, Mansoura, Egypt in order to reduce antibiotic resistance, and to minimize unnecessary costs. From 1/1/2019 to 31/12/2019, samples were obtained according to the site of infection, cultured on suitable media. Automated identification of isolates was performed by Vitek 2 system whereas antibiotic susceptibility testing was done by disc diffusion method. Isolates with multidrug resistance were also assessed for susceptibility by Vitek 2 system. Out of 3300 microbiologic samples, 1190 (36.1%) were positive. 862 of 1190 (72.4%) were gram-negative & 328 of 1190 (27.6%) gram-positive. The patterns of resistance observed were MRSA (37.1%), ESBL (8.5%) and Carbapenemases (8.9%). An antibiogram was designed for each infection type including the first-line therapy protocol. Antibiotic initiation or change should be done after sending appropriate cultures Once culture reports are available, the physician must step down to the narrowest spectrum antibiotic, the most efficient and cost-effective option.
![]() |
![]() |
![]() |
![]() |
![]() |